Status:
TERMINATED
Hemodynamic Effects of Chronic Administration of Spironolactone and/or Propranolol in Alcoholic Cirrhotic Patients
Lead Sponsor:
University Hospital, Angers
Conditions:
Alcoholic Cirrhosis
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
The aim of this study was assesment of splanchnic and systemic hemodynamic effects of chronic administration (2 month) of spironolactone or propranolol, alone or in association in alcoholic cirrhotic ...
Eligibility Criteria
Inclusion
- Indication of transjugular hepatic biopsy
- alcoholic cirrhosis
- presence of oesophageal varices ≤ stade 2
Exclusion
- renal insufficiency
- natremia ≤ 135 mmol/l
- vasoactive treatment in the last month before inclusion
- hepatocellular carcinoma
- positive HIV and HCV patients
- paracentesis in the last week before inclusion
- digestive bleeding in one last week
- oesophageal varices stade 3 or 2 with red signs
Key Trial Info
Start Date :
April 1 1995
Trial Type :
INTERVENTIONAL
End Date :
December 1 2003
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT00188045
Start Date
April 1 1995
End Date
December 1 2003
Last Update
November 1 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.